Masaharu Takahashi

Masaharu Takahashi

Speaker
Board member, COO, Goryo Chemical Inc.

Goryo Chemical's navigation drug enables to visualize specific target biophysical materials on intra or extra corporeal surgical operations. The Navigation Drug technology has great potential to cover any indication of diagnosis and surgical treatment by detecting the specific target biophysical materials. In case of cancer surgery, the Navigation Drug not only decreases remaining cancer cells and improves patient’s Quality of Life as a consequence of accelerating discernment between cancer and normal cells through surgery, but also makes the total surgical time shortened and improves the operational productivity as a consequence of providing real time pathological diagnosis to operation teams. We seek global out-licensing or co-developing partners regarding the Navigation Drug or repositioning of the potential partners’ ex-pipelines with using the Navigation Drug.
Connect
UPCOMING SESSIONS BY THIS SPEAKER
Connect
PAST EVENTS
Learn
Articles